Psychedelic venture firm Iter investments closes inaugural fund at over $20m

The fund launched in April 2021.

  • Iter Investments was founded by Dustin Robinson and Robert Velarde
  • Iter Investments’ portfolio includes Psilera, Beckley Psytech, Clairvoyant, Reset Pharma, Apex Labs, Wesana, Awakn Life Sciences and Freedom Bio
  • Iter Investments is headquartered in South Florida

Iter Investments, a venture capital firm that backs businesses operating in and around the burgeoning psychedelic industry, has closed its debut fund at over $20 million.

The fund launched in April 2021.

Iter Investments was founded by Dustin Robinson and Robert Velarde.

“Our mission has been and continues to be aiding entrepreneurs as they build great companies that use medical and scientific research to reimagine the health care industry’s approach to the underserved mental and behavioral health sectors,” said Robinson in a statement. “It has been a very successful year launching our initial fund and we have built incredible partnerships along the way.”

Iter Investments’ portfolio includes Psilera, Beckley Psytech, Clairvoyant, Reset Pharma, Apex Labs, Wesana, Awakn Life Sciences, and Freedom Bio.

Iter Investments has led several funding rounds and has a board seat on several of its portfolio companies.

Iter Investments is headquartered in South Florida.